Phase I first-in-man trial of ZP 2929 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2012
At a glance
- Drugs ZP 2929 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- 13 Sep 2012 Status changed from planning to recruiting, as reported in a Zealand Pharma media release (the first patient has been dosed).
- 27 Aug 2012 New trial record